Apollo Technology Capital Corporation, a significant shareholder of MediPharm Labs Corp., has urged shareholders to support change by voting for their nominated directors-John Fowler, Alan D. Lewis, David Lontini, Demetrios Mallios, Regan McGee, and Scott Walters-at the upcoming shareholder meeting. Apollo Capital, which owns approximately 3.0% of the company's common stock, expressed concerns over MediPharm's financial health, warning that the company may run out of money by November 2025. They have advised shareholders to disregard any "GREEN" proxy cards from the current management and instead support their call for board-level change to address the company's declining financial position. Shareholders are encouraged to read the detailed circular available on SEDAR+ for more information.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.